Genetic flaw linked to breast cancer.Much discussion of genetic links to breast cancer has centered on mutations in genes called BRCA-1 and BRCA-2, which predispose pre·dis·pose v. To make susceptible, as to a disease. some women to the disease. New research suggests that other genetic flaws also increase a woman's risk of breast cancer. Among these flaws are variants of three GST GST abbr. Greenwich sidereal time GST (in Australia, New Zealand, and Canada) Goods and Services Tax genes, named for the glutathione S-transferase enzymes that they encode. GST enzymes act as roving cleanup crews to detoxify de·tox·i·fy v. 1. To counteract or destroy the toxic properties of a substance. 2. To remove the effects of poison from something, such as the blood. 3. potential cancer-causing agents in the body. A flaw in the gene, GSTM GSTM Gatespace Telematics (supplier of systems and components for telematics) GSTM General System Test Module 1, that encodes one such enzyme has been associated with lung cancer. Other studies have hinted that cancer of the colon, bladder, and testicles Testicles Also called testes or gonads, they are part of the male reproductive system, and are located beneath the penis in the scrotum. Mentioned in: Testicular Cancer, Testicular Surgery, Vasectomy could also be linked to GST variations. To assess the role of these genetic variations in breast cancer, researchers at the Johns Hopkins Medical Institutions in Baltimore, Md., analyzed blood samples from 110 women who had breast cancer and 113 healthy women. Nearly all of the women were white, and most had gone through menopause. A postmenopausal post·men·o·paus·al adj. Of or occurring in the time following menopause. postmenopausal Change of life Gynecology adjective Referring to the time in ♀ when menstrual periods stop for ≥ 1 yr woman carrying a genetic variation of GSTM1 faces a 2.5 times greater risk of developing breast cancer than do her peers without that genetic flaw, the scientists report in the April 1 Journal of the National Cancer Institute. Moreover, a woman carrying variants of two or three of these enzyme-encoding genes encounters nearly four times the minimal risk, says study coauthor and molecular epidemiologist Paul T. Strickland. The GST variations are quite common. For example, while the GSTM1 flaw appeared in 56 of 90 postmenopausal women who had breast cancer, it also showed up in 36 of 90 healthy women. The proportion of women carrying the flaws for the other genes was lower but still considerably above the few percent of the population that carry the BRCA BRCA One of two genes (designated BRCA1 and BRCA2) that help repair damage to DNA, but when inherited in a defective state increase the risk of breast and ovarian cancer. mutations. Although GST variations aren't as potent as BRCA mutations, Strickland says, they may play a role in a substantial fraction of breast cancers. For example, the GST flaws may prove most consequential in the face of cancer-causing chemicals in the environment, he speculates. |
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion